Translating Innovation into Therapies

GEN Genetic Engineering & Biotechnology News | by Sue Pearson, Ph.D. | August 15, 2017

Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.

Astia CEO, Sharon Vosmek, keynotes the ON Helix 2017 conference; speaks on Astia Angels investment thesis: “Putting the C in Science: Commercialisation, Community and Capital”